| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 29-Mar-09 | | Total Revenue | 33,565 | 32,364 | 30,805 | 30,805 | | Cost of Revenue | 23,634 | 23,116 | 22,126 | 22,126 | | | Gross Profit | 9,832 | 9,248 | 8,679 | 8,679 | | | Operating Expenses | | Research Development | 2,494 | 2,514 | 2,743 | 2,743 | | Selling General and Administrative | 5,453 | 4,858 | 5,024 | 5,024 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 404 | 412 | 412 | 412 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,849 | 1,464 | 500 | 500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 124 | (311) | 115 | 115 | | Earnings Before Interest And Taxes | 2,247 | 1,153 | 615 | 615 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 2,247 | 1,153 | 615 | 615 | | Income Tax Expense | 438 | 904 | 729 | 729 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,809 | 249 | (114) | (114) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,809 | 249 | (114) | (114) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,809 | $249 | ($114) | ($114) |
|
0.11% Nasdaq 0.00%
Income Statement
